Citeline Podcasts Citeline
-
- Business
-
Citeline places biopharma and medical device professionals, and those who focus on these industries, at the forefront of knowledge and insight, by providing the perfect combination of news and information together with penetrating insight and analysis. Citeline is a leader in the field of healthcare industry information.
-
Digital Health Roundup: US FDA’s ‘Idea Lab’; Philips’ Roy Jakobs On AI Draft Framework; Apple Watch
In this month’s Digital Health Roundup, Medtech Insight’s Marion Webb highlights key interviews with Philips’ CEO Roy Jakobs on NAM’s draft framework on AI, BD’s CTO Beth McCombs R&D initiatives and HSS spine co-chair Sheeraz Qureshi on his vision for integrating AI tech. Hannah Daniel discusses the FDA’s new initiative to create an idea lab for medical device use at home and Apple Watch’s new feature to help people with Parkinson’s disease.
Listen to the podcast via the player below:
Medtech Insight articles addressing topics discussed in this episode:
BD’s CTO Beth McCombs Discusses Key Initiatives – AI/Gen AI; DE&I Strategy; Succession Planning
HSS Spine Surgeon Sees Potential For AI Chatbots, But Not To ‘Practice Medicine’
Philips Portfolio Includes ‘No Single Product That Does Not Use A Type of AI,’ Says CEO and AI Thought Leader Roy Jakobs
Discreet Gait Freezing Solution Brings Therapy With The Tap Of An Apple Watch
CDHR’s AR/VR Home Space Will Serve As An ‘Idea Lab’ For Device Stakeholders -
April Datamonitor Podcast 2024: AAN coverage
Flora and Emma are joined by Datamonitor’s CNS analysts Summer, Joseph, and Wen-Yu to discuss coverage from AAN.
Other platforms (in addition to SoundCloud):
Apple Podcasts - https://podcasts.apple.com/us/podcast/pharma-intelligence-podcasts/id923189836
Google Podcasts - https://podcasts.google.com/feed/aHR0cHM6Ly9mZWVkcy5zb3VuZGNsb3VkLmNvbS91c2Vycy9zb3VuZGNsb3VkOnVzZXJzOjEwNjU1NDkyOC9zb3VuZHMucnNz
TuneIn - https://tunein.com/podcasts/Business--Economics-Podcasts/Pharma-Intelligence-Podcasts-p1140128/
Spotify Podcasts - https://open.spotify.com/show/3DTc3eIh4xI6pVOd6DdO67 -
Scrip's Five Must-Know Things - 30 April 2024
Audio roundup of selected biopharma industry content from Scrip over the business week ended 26 April 2024. In this episode: 2023’s top selling drugs and the COVID cliff; falling sales force Roche to reassess priorities; Phase III immunology win for Sanofi; BMS’s strong pipeline: and which companies could be acquired next.
https://scrip.citeline.com/SC150182/Quick-Listen-Scrips-Five-MustKnow-Things -
2024 Global Generics & Biosimilars Awards
2024 Global Generics & Biosimilars Awards by Citeline
-
Podcast: Facilitating Patient Monitoring in CAR-T Development
Learn how molecular technology is enhancing patient safety for CAR-T clinical trials.
US FDA recently initiated class safety labeling changes after evaluating the safety of CAR-T cancer treatment therapies. What does this mean for developers in the CAR-T landscape? Listen to your free podcast to find out.
Listen in on the conversation as experts from Cerba discuss facilitating patient safety measures in CAR-T therapies by accurately identifying the integration of viral vectors, utilizing flow cytometry, and more.
Listen now as experts discuss answers to:
· What patient monitoring is required by the FDA?
· What molecular technology does Cerba use and how does it meet FDA requirements?
· What is the importance of cytometry assays in monitoring CAR-T cells?
· What are the opportunities for combining flow cytometry with genomic solutions?
· What key innovations are poised to improve patient monitoring in clinical trials? -
Drug Fix: US FDA Biosimilar Strategy, Gene Therapy Accelerated Approvals, FDA v. Partisan Politics
Pink Sheet reporter and editors discuss the impact of FDA biosimilar promotion guidance on the future of the interchangeability designation (:34), upcoming guidance on accelerated approval for gene therapies (14:15), and partisan attacks on the agency from Capitol Hill (27:13).
More On These Topics From The Pink Sheet
Rx Advertising: Interchangeability Doesn’t Mean Clinical Superiority To Other Biosimilars, FDA Says: https://pink.citeline.com/PS150143/Rx-Advertising-Interchangeability-Doesnt-Mean-Clinical-Superiority-To-Other-Biosimilars-FDA-Says
US FDA Gene Therapy Accelerated Approval Guidance Will Describe ‘Buckets’ Of Use Scenarios: https://pink.citeline.com/PS150140/US-FDA-Gene-Therapy-Accelerated-Approval-Guidance-Will-Describe-Buckets-Of-Use-Scenarios
Partisan Politics Returns To US FDA Congressional Oversight: https://pink.citeline.com/PS150114/Partisan-Politics-Returns-To-US-FDA-Congressional-Oversight
Customer Reviews
My Top Source for Industry News
I use all of Informa's sources of information, but in a busy world, the podcasts keep me most updated on the issues that affect my work as a healthcare consultant. I can't keep on top of everything, but with my podcasts loaded up, I can hear great analysis on what's most relevant today while running or doing chores around the house.
Too many “uh” during the conversation
Too many “uh” and broken sentences. I find it so painful to follow
Good information, bad delivery
Often times a podcast with very good information, but quite poorly delivered. As someone who regularly conducts market research interviews via telephone and web, I’m very familiar with reading through far too many colloquialisms, filler words, and trite expressions. Words and phrases such as “right “and you know” “um” “and” “uh” make it painful to listen to in any regular basis.